Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by an Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team. 

Biotechnology

Pharmaceutical

Centessa Pharmaceuticals

Centessa Pharmaceuticals' headquarters in Cambridge, MA, United States

Karen Anderson

Danielle Hyman

Tia Bush

Susan Kozauer

David Chao

Peter Ward

Iqbal Hussain

Gregory Weinhoff

Mario Alberto Accardi

Pennylynn Makiya

John Crowley

Sanja Mutabdzija

Andriy Kirmach

Tracey Klees

Erin Vickers

Matt Bigert

Kim McCormick

Henry Wolfe

Michael Miller

Linda Hook-Dinnocenzo

Dori Metz Parmelee

Valerie Duca

Richard M.

Kristen Sheppard

Craig Davis

Kathryn Henley

Willem R.

Jeff Wald

Niall Foy

Eileen Leary

Ronan O'Dwyer

Charlene Stoudt

Sai Pulukuri

Yashar Salek

Mandy Sterkel

Yong Li

Deborah Hartman

Mary Lynne Hedley

Carol Stuckley

Mathias Hukkelhoven

Francesco De Rubertis

Brett Zbar

Samarth Kulkarni

Arjun Goyal

This department oversees and coordinates clinical operations, clinical pharmacology, and regulatory affairs to facilitate the development of medical products.

Clinical Development

This department provides strategic guidance and oversight for the organization's overall direction and decision-making.

Executive Leadership

This department oversees the planning, execution, and management of clinical trials to ensure they are conducted efficiently and in compliance with regulatory standards.

Clinical Operations

The Quality Assurance and Compliance Team at Centessa Pharmaceuticals is responsible for ensuring that all drug development processes meet regulatory standards and internal quality benchmarks. This includes overseeing Good Clinical Practice (GCP) compliance, maintaining quality systems, managing product quality, and ensuring accurate global consolidation and international reporting. The team plays a vital role in safeguarding the integrity and safety of Centessa’s biopharmaceutical advancements.

Quality Assurance and Compliance Team

The Research and Development team at Centessa Pharmaceuticals is responsible for advancing the company's portfolio of highly validated drug programs. This involves overseeing the strategic and operational aspects of drug R&D, including the development and management of chemistry, manufacturing, and controls (CMC) processes for biologics. The team, composed of experienced leaders in pharmacology, immunooncology, and analytical research, ensures each subsidiary program progresses efficiently from concept through to clinical development.

Research and Development

The Leadership Team at Centessa Pharmaceuticals is responsible for shaping the strategic direction and operational efficiency of the company. Comprised of key executives including the CEO, Chief Financial Officer, and Chief Technology & Quality Officer, this team drives the vision of innovative drug development while overseeing financial stability, quality assurance, and administrative functions across the organization. Their collaborative approach ensures that each subsidiary is aligned with Centessa’s overarching goals, facilitating the effective advancement of its diverse portfolio of biopharmaceutical programs.

Leadership Team

Centessa Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Development

Executive Leadership

Clinical Operations

Quality Assurance and Compliance Team

Research and Development

Leadership Team

Offices

Centessa Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Development

Executive Leadership

Clinical Operations

Quality Assurance and Compliance Team

Research and Development

Leadership Team

Offices

Related companies